CONTROLLED SUB-TESTOSTERONE

The bill IL SB3323 proposes changes to the Illinois Controlled Substances Act by exempting testosterone and certain other medications from the Prescription Monitoring Program. It requires the Department of Human Services to remove all existing records of testosterone prescriptions by January 1, 2027, and to ensure no new records are created after that date. The Department must also update its rules to align with this change.

Supporters of IL SB3323 argue that removing testosterone from the Prescription Monitoring Program will improve access for patients who need it for legitimate medical reasons. They believe this will help reduce stigma and promote better health outcomes for individuals who rely on testosterone therapy.

Critics of IL SB3323 contend that exempting testosterone from monitoring could lead to increased misuse and abuse of the substance. They express concerns that the lack of oversight may endanger public health and undermine efforts to regulate controlled substances effectively.